The glymphatic system and meningeal lymphatic vessels function as the brain's waste-clearance network, removing amyloid-β and tau proteins through cerebrospinal and interstitial fluid exchange. Dysfunction in this system correlates with Alzheimer's pathology, positioning targeted modulation of glymphatic clearance as a precision medicine strategy to interrupt disease progression.
Key Points
- Brain possesses active lymphatic waste-clearance system distinct from immune-privileged dogma
- Glymphatic dysfunction allows toxic protein accumulation triggering Alzheimer's pathology
- Therapeutic interventions—physical, pharmacologic, surgical—now target glymphatic pathway restoratio
Longevity Analysis
Understanding the brain's waste-clearance infrastructure reframes Alzheimer's as fundamentally a problem of impaired detoxification rather than solely protein aggregation. This distinction enables intervention before pathological cascades become entrenched. Whether through enhancing the fluidity of cerebrospinal circulation, removing barriers to lymphatic flow, or supporting the nervous system's own housekeeping capacity, the therapeutic window shifts from late-stage symptom management to restoring the body's intrinsic cleanup mechanisms—a principle that extends across multiple organ systems and metabolic states.
Original published by Wiley Aging Cell, by Bingbing Song, Wei Wang, Siqi Liu, Xi Jin, Yan Qi, Mingquan Li, Dongjie Yue, Yu Liu, Xiangqi Li, Lei Yin, Lina Feng .